Prevalence and molecular mechanism of macrolide resistance in β-haemolytic streptococci in The Netherlands

International Journal of Antimicrobial Agents

Volumn 35, Issue 6, 2010, Pages 590-592

  Van Leer Buter, C C ^a   Mouton, J W ^a,b   Klaassen, C H W ^b   Handgraaf, C M A ^a   Sunnen, S ^a   Melchers, W J G ^a   Sturm, P D J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Haemolytic streptococci; Macrolide resistance; Mef; MLSB

Indexed keywords

BACTERIAL PROTEIN; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; PROTEIN ERMA; PROTEIN ERMB; PROTEIN MEFA; PROTEIN MEFE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; CONTROLLED STUDY; HUMAN; MOLECULAR MECHANICS; NETHERLANDS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS GROUP C; STREPTOCOCCUS GROUP G;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENES, BACTERIAL; HUMANS; MACROLIDES; NETHERLANDS; PREVALENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 77951764659     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.02.010     Document Type: Article

References (14)

1. Amezaga M., McKenzie H. Molecular epidemiology of macrolide resistance in β-haemolytic streptococci of Lancefield groups A, B, C and G and evidence for a new mef element in group G streptococci that carries allelic variants of mef and msr(D). J Antimicrob Chemother 2006, 57:443-449.
2. Bingen E., Leclercq R., Fitoussi F., Brahimi N., Malbruny B., Deforche D., et al. Emergence of group A streptococcus strains with different mechanisms of macrolide resistance. Antimicrob Agents Chemother 2002, 46:1199-1203.
3. Poyart C., Jardy L., Quesne G., Berche P., Trieu-Cuot P. Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother 2003, 47:794-797.
4. Klomberg D., de Valk H., Mouton J., Klaassen C. Rapid and reliable real-time PCR assay for detection of the macrolide efflux gene and subsequent discrimination between its distinct subclasses mef(A) and mef(E). J Microbiol Methods 2005, 60:269-273.
5. Pérez-Trallero E., Montes M., Orden B., Tamayo E., García-Arenzana J., Marimón J. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob Agents Chemother 2007, 51:1228-1233.
6. Arpin C., Daube H., Tessier F., Quentin C. Presence of mefA and mefE genes in Streptococcus agalactiae. Antimicrob Agents Chemother 1999, 43:944-946.
7. Muller A., Valkenburg-van den Berg A., Kreft D., Oostvogel P., Sprij A., van Belkum A. Low rate of carriage of macrolide-resistant group B streptococci in pregnant women in The Netherlands. Eur J Obstet Gynecol Reprod Biol 2008, 137:17-20.
8. Marimón J., Valiente A., Ercibengoa M., García-Arenzana J., Pérez-Trallero E. Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae. Antimicrob Agents Chemother 2005, 49:5069-5074.
9. Gherardi G., Imperi M., Baldassarri L., Pataracchia M., Alfarone G., Recchia S., et al. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J Clin Microbiol 2007, 45:2909-2916.
10. Buxbaum A., Forsthuber S., Sauermann R., Gattringer R., Graninger W., Georgopoulos A. Development of macrolide-resistance and comparative activity of telithromycin in streptococci in Austria, 1996-2002. Int J Antimicrob Agents 2004, 24:397-400.
11. Broyles L.N., Van Beneden C., Beall B., Facklam R., Shewmaker P.L., Malpiedi P., et al. Population-based study of invasive disease due to β-hemolytic streptococci of groups other than A and B. Clin Infect Dis 2009, 48:706-712.
12. Merino Díaz L., Torres Sánchez M., Aznar Martín J. Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of β-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain. Clin Microbiol Infect 2008, 14:85-87.
13. Kataja J., Seppälä H., Skurnik M., Sarkkinen H., Huovinen P. Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob Agents Chemother 1998, 42:1493-1494.
14. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002, 34:482-492.